Zhejiang Hisun Pharmaceutical – World Class Benchmarking
Company: Zhejiang Hisun Pharmaceutical Company Limited
Bloomberg ticker: 600267 SH
Market cap: US$1,424m
Background: Zhejiang Hisun Pharmaceutical Company Limited is a Chinese company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products.
World Class Benchmarking of Zhejiang Hisun Pharmaceutical
- Profitable Growth rank of 10 was down compared to the prior period’s 9th rank
- This is poor performance compared to 380 large Health Care companies worldwide
- Profitability rank of 9 was better than its Growth rank of 10
- Profitability rank of 9 was the same compared to the prior period’s 9th rank
- This is poor performance compared to peers
- Growth rank of 10 was the same compared to the prior period’s 10th rank
- This is poor performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.